Sign in
4

Changes in Ownership

Grace Therapeutics, Inc. Filed Acc 0001140361-25-014266

Options or other derivatives

  • VP Program Management acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Kumar Amresh VP Program Management 2025-04-14 Grant or award · Stock Option (Right to Buy) +30,000 30,000 D
Loading xslF345X05/form4.xml…